Dean Investment Associates’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
RA
Dean Investment Associates's HAE Position: Q3 2024 in Review
Dean Investment Associates sold out of Haemonetics (HAE) in Q3 2024, closing a stake of 21,922 shares — an estimated $1.81M sold.
Dean Investment Associates first reported a position in HAE in Q2 2014 and held it in 15 quarters. The position peaked at $1.86M in Q1 2024. 306 funds tracked by Wall St. Rank hold HAE as of Q3 2024.
- Dean Investment Associates reported no remaining Haemonetics position as of Q3 2024 after selling out during the quarter.
- Dean Investment Associates sold 21,922 Haemonetics shares in Q3 2024, an estimated $1.81M.
- Dean Investment Associates first reported a position in Haemonetics in Q2 2014 and held it in 15 quarters.
- Dean Investment Associates's Haemonetics position peaked at $1.86M in Q1 2024.
- 306 funds tracked by Wall St. Rank held Haemonetics as of Q3 2024.
Based on Dean Investment Associates's 13F filing for Q3 2024, filed 15 Nov 2024.